U.S., Oct. 22 -- An application to own the trademark for 'ENLANPPI' has been filed on Mar. 10, 2025.
Owner(s):
Inozyme Pharma, Inc.; 321 Summer Street, Suite 400, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations and substances for the treatment of bone diseases and disorders; Pharmaceutical preparations and substances for the treatment of pathological calcification; Pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; Pharmaceutical preparations and substances for the treatment of kidney diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 05...